The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.

Article Details

Citation

Orvisky E, Park JK, Parker A, Walker JM, Martin BM, Stubblefield BK, Uyama E, Tayebi N, Sidransky E

The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.

Hum Mutat. 2002 Apr;19(4):458-9.

PubMed ID
11933202 [ View in PubMed
]
Abstract

Mutations in the gene encoding for the lysosomal enzyme glucocerebrosidase (GBA) result in Gaucher disease. In this study, seven novel missense mutations in the glucocerebrosidase gene (A136E, H162P, K198E, Y205C, F251L, Q350X and I402F) and a splice site mutation (IVS10+2T-->A) were identified by direct sequencing of three amplified segments of the glucocerebrosidase gene. Five of the novel mutations were found in patients with neuronopathic forms of Gaucher disease, two of which, K198E and F251L, appear to be associated with type 2 Gaucher disease.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
GlucosylceramidaseP04062Details